This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Infeld, B. Articles by Hopper, J. L. Search for Related Content PubMed PubMed Citation Articles by Infeld, B. Articles by Hopper, J. L. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

(Stroke. 1996;27:1524-1529.)
© 1996 American Heart Association, Inc.

Articles

Streptokinase Increases Luxury Perfusion After Stroke

Bernard Infeld, MBBS, FRACP; Stephen M. Davis, MD, FRACP; Geoffrey A. Donnan, MD, FRACP; Meir Lichtenstein, MBBS, FRACP; Alison E. Baird, MBBS; David Binns, DipAppSci; Peter J. Mitchell, MBBS, FRACR John L. Hopper, PhD

the Departments of Neurology (B.I., S.M.D.), Nuclear Medicine (M.L., D.B.), and Radiology (P.J.M.), Royal Melbourne Hospital; Department of Neurology (G.A.D., A.E.B.), Austin Hospital; and the Department of Public Health and Community Medicine, University of Melbourne (J.L.H.); Melbourne, Australia.

Background and Purpose Recent acute stroke trials have reported that intravenous streptokinase is associated with an increased risk of adverse outcomes. We aimed to study the effect of streptokinase on the nature of reperfusion and the relation between reperfusion and clinical outcome.

Methods We studied 24 patients in the Australian Streptokinase Trial with acute middle cerebral cortical infarction using ^99mTc–hexamethylpropyleneamine oxime single-photon emission CT. Eleven of the 24 patients were scanned before therapy and again 24 hours later. The remaining 13 were scanned once either before therapy (1 patient) or after therapy (12 patients). All patients had outcome scans after 3 months. Infarct hypoperfusion was measured with a validated volumetric technique. Neurological impairment and functional outcome were assessed with the Canadian Neurological Scale and the Barthel Index, respectively.

Results Fifteen patients received streptokinase and 9 received placebo. There was no difference in early reperfusion between streptokinase and placebo. However, streptokinase was associated with a greater amount of nonnutritional reperfusion than was placebo (P=.04). This luxury perfusion was associated with poor functional outcome (P=.02).

Conclusions This study suggests that streptokinase augments luxury perfusion after stroke. Luxury perfusion is associated with a worse outcome, which might be due in part to reperfusion injury.

Key Words: cerebrovascular disorders • reperfusion • streptokinase • thrombolytic therapy • tomography, emission computed

This article has been cited by other articles:

				V. A. Nagar, A. M. McKinney, A. T. Karagulle, and C. L. Truwit Reperfusion Phenomenon Masking Acute and Subacute Infarcts at Dynamic Perfusion CT: Confirmation by Fusion of CT and Diffusion-Weighted MR Images Am. J. Roentgenol., December 1, 2009; 193(6): 1629 - 1638. [Abstract] [Full Text] [PDF]

				C. Cornu, F. Boutitie, L. Candelise, J. P. Boissel, G. A. Donnan, M. Hommel, A. Jaillard, and K. R. Lees Streptokinase in Acute Ischemic Stroke: An Individual Patient Data Meta-Analysis : The Thrombolysis in Acute Stroke Pooling Project Stroke, July 1, 2000; 31(7): 1555 - 1560. [Abstract] [Full Text] [PDF]

				B. Infeld, S. M. Davis, G. A. Donnan, M. Yasaka, M. Lichtenstein, P. J. Mitchell, and G. J. Fitt Nimodipine and Perfusion Changes After Stroke Stroke, July 1, 1999; 30(7): 1417 - 1423. [Abstract] [Full Text] [PDF]

				C. Motto, A. Ciccone, E. Aritzu, E. Boccardi, C. De Grandi, A. Piana, and L. Candelise Hemorrhage After an Acute Ischemic Stroke Stroke, April 1, 1999; 30(4): 761 - 764. [Abstract] [Full Text] [PDF]

				P. A. Barber, S. M. Davis, B. Infeld, A. E. Baird, G. A. Donnan, D. Jolley, and M. Lichtenstein Spontaneous Reperfusion After Ischemic Stroke Is Associated With Improved Outcome Stroke, December 1, 1998; 29(12): 2522 - 2528. [Abstract] [Full Text] [PDF]

				J. C. Grotta and A. V. Alexandrov tPA-Associated Reperfusion After Acute Stroke Demonstrated by SPECT Stroke, February 1, 1998; 29(2): 429 - 432. [Abstract] [Full Text] [PDF]

				J V Bowler, J P H Wade, B E Jones, K S Nijran, and T J Steiner Natural history of the spontaneous reperfusion of human cerebral infarcts as assessed by 99mTc HMPAO SPECT J. Neurol. Neurosurg. Psychiatry, January 1, 1998; 64(1): 90 - 97. [Abstract] [Full Text]

				A. V. Alexandrov, J. C. Masdeu, M. D. Devous Sr, S. E. Black, and J. C. Grotta Brain Single-Photon Emission CT With HMPAO and Safety of Thrombolytic Therapy in Acute Ischemic Stroke : Proceedings of the Meeting of the SPECT Safe Thrombolysis Study Collaborators and the Members of the Brain Imaging Council of the Society of Nuclear Medicine Stroke, September 1, 1997; 28(9): 1830 - 1834. [Abstract] [Full Text]